Alvotech Ordinary Shares ALVO 深 沪
已收盘 09-20 16:00:00 美东时间
11.12
-0.060
-0.54%
华盛通- 最 高11.20
- 今 开11.19
- 成交量 6.48万股
- 最 低 10.95
- 昨 收 11.18
- 总市值 30.69亿
- 52周最高 18.00
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 8.30
- 委 比 -96.40%
- 总股本 2.76亿
- 历史最高 18.00
- 量 比 0.79
- 振 幅 2.24%
- 历史最低 5.20
- 每 手 1
- 风险率 2.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.
09-12 02:59
Cigna PBM Express Scripts to remove Humira from many formularies
AbbVie's Humira (adalimumab) will be taken off the formulary lists of many Cigna (NYSE:CI) health care plans in 2025 in favor of cheaper biosimilar version. Members next year can get Simlandi from Tev...
08-27 03:03
Vipshop, Hesai Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the S&P 500 futures gainin...
08-20 20:16
Alvotech’s Strong Q2 Performance and Positive Outlook Justify Buy Rating
In a report released on August 16, Balaji Prasad from Barclays maintained a Buy...
08-18 23:45
Alvotech shares are trading lower. The company reported H1 financial results.
Alvotech shares are trading lower. The company reported H1 financial results.
08-16 04:38
Alvotech GAAP EPS of -$0.61, revenue of $236M
Alvotech press release (NASDAQ:ALVO): 1H GAAP EPS of -$0.61. Revenue of $236M (+938.7% Y/Y). Adjusted EBITDA in the first six months was $64 million, compared to negative ($147) million for the same p...
08-16 04:28
Alvotech Reports Revenue Surge Amidst Expansion
Alvotech (ALVO) has released an update. Alvotech, a biotech firm specializing i...
08-16 04:27
Alvotech’s biosimilar to Regeneron’s Eylea under EU review
Alvotech (NASDAQ:ALVO) announced Thursday that the EU regulators accepted for review AVT06, its proposed biosimilar against blockbuster eye disorder therapy, Eylea, marketed by Regeneron (NASDAQ:REGN)...
08-16 02:02
Alvotech’s Biosimilar AVT06 Eyes European Market
Alvotech (ALVO) has released an update. Alvotech, a global biotech firm, announ...
08-15 20:28
EMA Accepts Alvotech and Advanz Pharma's Application for Eylea Biosimilar
Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a
08-15 16:32
